Cinclus Pharma Appoints Maria Engström as Chief Financial Officer
Stockholm, Sweden: Cinclus Pharma Holding AB (“Cinclus Pharma”), a biopharmaceutical company focused on the development of a novel treatment for gastroesophageal reflux disease (“GERD”), today announced the appointment of Maria Engström as Chief Financial Officer (CFO). Maria has extensive experience in the pharmaceutical industry and most recently from Sedana Medical where she was CFO from 2017 to early 2021.Maria Engström assumed the position already in August 2021. ” The company are delighted in having recruited Maria Engström to Cinclus Pharma” said Christer Ahlberg, CEO. "Maria